These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1391144)
1. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis]. Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144 [TBL] [Abstract][Full Text] [Related]
2. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Carvalhinhos A; Fidalgo P; Freire A; Matos L Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103 [TBL] [Abstract][Full Text] [Related]
3. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789 [TBL] [Abstract][Full Text] [Related]
4. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms]. Fehr HF Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493 [TBL] [Abstract][Full Text] [Related]
6. [Morpho-functional characteristics of reflux gastritis in patients after cholecystectomy and without cholecystectomy]. Scalon P; Di Mario F; Rugge M; Meggiato T; Baffa R; Mantovani G; Plebani M; Cutolo M; Del Favero G Minerva Gastroenterol Dietol; 1991; 37(2):113-6. PubMed ID: 1742396 [TBL] [Abstract][Full Text] [Related]
7. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. De Nutte N; Van Ganse W; Witterhulghe M; Defrance P Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906 [TBL] [Abstract][Full Text] [Related]
8. Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. Santarelli L; Gabrielli M; Candelli M; Cremonini F; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):975-9. PubMed ID: 12923369 [TBL] [Abstract][Full Text] [Related]
9. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845 [TBL] [Abstract][Full Text] [Related]
10. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases]. Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709 [TBL] [Abstract][Full Text] [Related]
11. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010 [TBL] [Abstract][Full Text] [Related]
12. [Duodenogastric reflux in patients with functional dyspepsia]. Swiatczak C; Jawień A; Swiatkowski M; Słomiński JM; Kowiański Z Wiad Lek; 1994 May; 47(9-10):329-32. PubMed ID: 7817588 [TBL] [Abstract][Full Text] [Related]
13. Drug therapy of reflux oesophagitis: an update. Tytgat GN Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792 [TBL] [Abstract][Full Text] [Related]
14. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. McKenna CJ; Mills JG; Goodwin C; Wood JR Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711 [TBL] [Abstract][Full Text] [Related]
15. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia. Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685 [TBL] [Abstract][Full Text] [Related]
16. [Incidence of Helicobacter pylori infections in patients with duodenogastric reflux]. Poniewierka E; Gościniak G; Matysiak-Budnik T Wiad Lek; 1993 Apr; 46(7-8):271-3. PubMed ID: 8249413 [TBL] [Abstract][Full Text] [Related]
17. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. Halter F; Staub P; Hammer B; Guyot J; Miazza BM J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy. Scalon P; Di Mario F; Del Favero G; Meggiato T; Rugge M; Baffa R; Basso D; Battistel M; Plebani M; Naccarato R Acta Gastroenterol Belg; 1993; 56(2):215-8. PubMed ID: 8368047 [TBL] [Abstract][Full Text] [Related]
19. Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. Barbara L; Biasco G; Capurso L; Dobrilla G; Lalli A; Paganelli GM; Pallone F; Torsoli A Am J Gastroenterol; 1990 Sep; 85(9):1109-13. PubMed ID: 2202200 [TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]